Reportlinker. Com announced the release of "(2020-2025) growth, trend and forecast of pharmaceutical glass packaging market". Glass packaging bottle is one of the main packaging materials in the pharmaceutical industry, because it limits the alkalinity and hydrolysis resistance of glass containers. In 2019, the global market value of medical glass packaging bottles was 151.55 billion US dollars, and it is expected to reach 256.97 billion US dollars in 2025. During this period, the CAGR was 9.17%.
The pharmaceutical and medical device industries are highly regulated and emphasize the safe and sustainable development of manufacturing and packaging processes. Legislation has been enacted throughout the health sector to combat counterfeit drugs and medical devices. For example, in October 2019, Corning announced the establishment of a united pharmaceutical company, which was approved by FDA. Corning valor glass will be the main packaging bottle of pharmaceutical products in the market. This innovative glass packaging bottle solution is following the new trend of the market.
Pharmaceutical growth in emerging economies is driving the market. Glass bottle manufacturers and suppliers are focused on moving their bases to China, India and Brazil, as the pharmaceutical industry in these countries provides more and more opportunities, especially in the field of generic drugs. For example, in April 2019, Schott invested R $50 million to produce pharmaceutical tubes in Rio de Janeiro as part of its global growth strategy.
In addition, India has 60000 general brands in 60 treatment categories and produces more than 500 different active pharmaceutical ingredients. The goal of the pharmaceutical department is to make the country an end-to-end drug R & D center under its "pharmaceutical Vision 2020".
With the improvement of recyclability, the commodity value of glass is driving the market. Drug packaging accounts for a small proportion of waste because most of it is used as a material for glass. In addition, the glass packaging bottle is also 100% recyclable, which makes it an ideal packaging bottle choice from an environmental point of view. In addition, colored glass, such as amber glass and red colored glass, can protect its contents from ultraviolet rays and certain wavelengths. Glass containers can be easily disinfected, making them ideal materials for drug packaging.
Piramal enterprise announced the use of environmentally friendly power supply and recycled glass to reduce our overall energy consumption and carbon emissions, thereby promoting a safer and greener enterprise working environment. Recently, the company has also developed thin and light glass bottles, further reducing the company's energy and raw material consumption. Similarly, Gerresheimer is committed to sustainable trends across the sector. The company has produced glass in Belgium using post consumer recycling (PCR) materials for more than a decade.
In addition, the proliferation of covid-19 had a negative impact on the market, initially due to supply chain disruptions caused by global production delays. Later, however, the situation changed. For example, FEVE (European Federation of glass container and machine glass manufacturers) called on the authorities to recognize the key role of glass bottle manufacturing and subcontracting, and excellently led the continuous manufacturing of all factories to provide people with food, beverage and medicine.
However, in terms of logistics, it is difficult for bottle, vial and ampoule manufacturers to supply pharmaceutical companies. For example, agiglaspac pharmaceutical sector, which currently accounts for 30-32% of India's pharmaceutical packaging bottle industry, is facing problems of blocked production, affected supply and increased inventory. So far, the company is partially using limited raw materials.
Location：
